Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Feixiang Health Technology is a digital health enterprise specializing in AI-powered solutions for chronic respiratory disease management. The company's core offering is an integrated platform that combines smart medical devices with mobile applications to monitor conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. By leveraging cloud-based big data analytics, Feixiang Health provides clinicians with actionable insights into patient health trends and medication adherence. Their mission is to transform traditional reactive care into a proactive, data-driven management model that improves long-term patient outcomes. The company has received significant backing from prominent venture capital firms to expand its digital therapeutics footprint in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Feixiang Health Technology.